XML 37 R19.htm IDEA: XBRL DOCUMENT v3.19.1
DAMAGES PROVISION
12 Months Ended
Dec. 31, 2018
DAMAGE PROVISION  
DAMAGE PROVISION

14.    DAMAGES PROVISION

 

 

 

 

 

 

 

 

 

 

 

 

    

December 31, 

    

December 31, 

    

December 31,

 

 

2018

 

2017

 

2016

 

 

 

 

 

 

 

 

 

 

Initial damages

 

$

 —

 

$

 —

 

$

70,000,000

Enhanced damages

 

 

 —

 

 

 —

 

 

21,000,000

Pre-judgment interest

 

 

 —

 

 

 —

 

 

20,675,154

Accrued post-judgment interest

 

 

 —

 

 

 —

 

 

105,942

 

 

$

 —

 

$

 —

 

$

111,781,096

 

On May 19, 2016, in the Company’s primary U.S. litigation with CardiAQ, following a trial in Boston, Massachusetts, a jury awarded $70 million on certain trade secret claims made by CardiAQ.  On October 31, 2016, during post-trial motions, the judge awarded $21 million enhanced damages on those claims and on January 18, 2017 during post-trial motions the judge awarded $20,675,154 in pre-judgment interest and $2,354 per day in post-judgment interest from November 21, 2016.    During 2017 interest of $738,021 was accrued.  On November 13, 2017, the final mandate of the Appeals Court was issued and on November 17, 2017, a total of $112,519,117 was paid to settle the remaining damages and interest awards in full.